ProShares Ultra Health Care (NYSEARCA:RXL) Short Interest Update

ProShares Ultra Health Care (NYSEARCA:RXLGet Free Report) was the recipient of a significant decrease in short interest in the month of February. As of February 13th, there was short interest totaling 4,856 shares, a decrease of 39.6% from the January 29th total of 8,046 shares. Approximately 0.3% of the shares of the company are short sold. Based on an average trading volume of 12,885 shares, the days-to-cover ratio is presently 0.4 days. Based on an average trading volume of 12,885 shares, the days-to-cover ratio is presently 0.4 days. Approximately 0.3% of the shares of the company are short sold.

Institutional Investors Weigh In On ProShares Ultra Health Care

Several hedge funds have recently bought and sold shares of the stock. Envestnet Asset Management Inc. acquired a new position in shares of ProShares Ultra Health Care in the 2nd quarter valued at $468,000. Steward Partners Investment Advisory LLC boosted its stake in shares of ProShares Ultra Health Care by 50.0% during the 2nd quarter. Steward Partners Investment Advisory LLC now owns 900 shares of the company’s stock worth $37,000 after acquiring an additional 300 shares in the last quarter. Toth Financial Advisory Corp grew its position in shares of ProShares Ultra Health Care by 4.7% during the 4th quarter. Toth Financial Advisory Corp now owns 9,201 shares of the company’s stock valued at $477,000 after acquiring an additional 412 shares during the period. Csenge Advisory Group acquired a new stake in shares of ProShares Ultra Health Care during the 4th quarter valued at about $297,000. Finally, Osaic Holdings Inc. increased its stake in shares of ProShares Ultra Health Care by 604.9% in the 4th quarter. Osaic Holdings Inc. now owns 15,431 shares of the company’s stock valued at $799,000 after purchasing an additional 13,242 shares in the last quarter.

ProShares Ultra Health Care Price Performance

NYSEARCA:RXL traded up $1.87 during mid-day trading on Friday, hitting $54.89. The company’s stock had a trading volume of 6,537 shares, compared to its average volume of 10,327. The business’s fifty day moving average is $52.76 and its two-hundred day moving average is $48.20. The stock has a market cap of $93.31 million, a price-to-earnings ratio of 24.86 and a beta of 1.28. ProShares Ultra Health Care has a 1 year low of $36.23 and a 1 year high of $55.58.

About ProShares Ultra Health Care

(Get Free Report)

ProShares Ultra Health Care (the Fund) seeks daily investment results that correspond to twice (200%) the daily performance of the Dow Jones U.S. Health Care Index (the Index). The Fund intends to invest at least 80% of its net assets, including any borrowings for investment purposes, under normal circumstances, to equity securities contained in the Index and/or financial instruments that, in combination, have similar economic characteristics. The Fund also intends to invest assets not invested in financial instruments, in debt instruments and/or money market instruments.

Recommended Stories

Receive News & Ratings for ProShares Ultra Health Care Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ProShares Ultra Health Care and related companies with MarketBeat.com's FREE daily email newsletter.